Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Alanine in NASH
NCT00586885Phase 2Completed
- Sponsor
- Keith D Lindor
- Start
- Feb 2004
- Primary completion
- Jun 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of l-alanine in Nonalcoholic steatohepatitis (NASH), sponsored by Keith D Lindor. Primary endpoints: Safety and Tolerability of Long-term L-alanine Supplementation at 1 year, Liver Biochemistry at 1 year and 1 more. Started Feb 2004; status: completed.
02
Drugs
l-alanine
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT00586885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00586885.